ArticleFrontiers in neurology2025
Predicting the prognosis of patients with sudden sensorineural hearing loss by analyzing the audiometric curve of the unaffected ear.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to extract potential information from the audiograms of the unaffected ear in patients with unilateral sudden sensorineural hearing loss (USSNHL). It explores the relationship between the characteristics of the audiograms of the unaffected ear and the treatment effectiveness for USSNHL. Additionally, the research presents the findings in a way that enhances communication and allows for verification. Methods: The study employs piecewise curve fitting to simplify the changing trend of audiograms in the unaffected ear of USSNHL patients into the slopes of three straight lines. Utilizing Python, the research team conducts a cluster analysis on the 229 patients' audiometric characteristics and trains the clustering results into an algorithm model. After clustering, the team applies statistical methods such as regression analysis to explore the correlation between the clustering results and the therapeutic efficacy. Results: The study completes the clustering analysis and encapsulates the trained model into an executable program. The algorithm clusters the patients into Cluster X and Cluster Y based on the audiogram characteristics of the unaffected ear. The clustering results demonstrate a significant correlation with the treatment efficacy. Regression analysis shows that Cluster Y patients achieve an average improvement in hearing threshold post-treatment that is 6.52 dB higher than that of Cluster X. The relative risk of "No improvement" for Cluster Y is half that of Cluster X. Additionally, age and the audiogram type of the affected ear also contribute to the prognosis of USSNHL to varying degrees. Furthermore, the research team submits the trained clustering model and corresponding spreadsheet as attachments, facilitating dissemination and validation. Conclusion: Regression analysis confirms that the clustering results are independent factors indicative of the prognosis in patients with USSNHL. The data exerting the most significant influence on clustering analysis outcomes were derived from the evolving auditory threshold patterns in the posterior segment of audiometric curves obtained from unaffected ears. This observation indicates a strong correlation between mid-to-high frequency threshold progression in the contralateral ear and clinical prognosis among patients with USSNHL. The clustering methodology demonstrated robust classification efficacy for auditory data lacking explicit cutoff values, ultimately enabling refined patient stratification through multidimensional pattern recognition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.